NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges

Autor: Thierry Kuntzer, Jean-Marc Good, Mayte Castro Jiménez, Christel Tran, David Benninger, Isis Atallah, Andrea Superti-Furga
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Pediatrics
medicine.medical_specialty
Movement disorders
Deficiency syndrome
medicine.medical_treatment
Case Report
QH426-470
Cerebrotendinous Xanthomatosis
03 medical and health sciences
Epilepsy
0302 clinical medicine
Adrenal insufficiency
Spastic
Genetics
Medicine
X-linked adrenoleukodystrophy
next-generation sequencing (NGS)
neurogenetic disorders
treatable diseases
Genetics (clinical)
ATP Binding Cassette Transporter
Subfamily D
Member 1/genetics

Adrenoleukodystrophy/diagnosis
Adrenoleukodystrophy/genetics
Adult
Carbohydrate Metabolism
Inborn Errors/diagnosis

Carbohydrate Metabolism
Inborn Errors/genetics

Cholestanetriol 26-Monooxygenase/genetics
Female
Genetic Testing/methods
Glucose Transporter Type 1/genetics
High-Throughput Nucleotide Sequencing/methods
Humans
Male
Middle Aged
Monosaccharide Transport Proteins/deficiency
Monosaccharide Transport Proteins/genetics
Sequence Analysis
DNA/methods

Xanthomatosis
Cerebrotendinous/diagnosis

Xanthomatosis
Cerebrotendinous/genetics

cerebrotendinous xanthomatosis
glucose transporter type 1 deficiency syndrome
business.industry
medicine.disease
030104 developmental biology
Adrenoleukodystrophy
medicine.symptom
business
030217 neurology & neurosurgery
Ketogenic diet
Zdroj: Genes, Vol 12, Iss 695, p 695 (2021)
Genes, vol. 12, no. 5, pp. 695
Genes
ISSN: 2073-4425
Popis: The identification of neurological disorders by next-generation sequencing (NGS)-based gene panels has helped clinicians understand the underlying physiopathology, resulting in personalized treatment for some rare diseases. While the phenotype of distinct neurogenetic disorders is generally well-known in childhood, in adulthood, the phenotype can be unspecific and make the standard diagnostic approach more complex. Here we present three unrelated adults with various neurological manifestations who were successfully diagnosed using NGS, allowing for the initiation of potentially life-changing treatments. A 63-year-old woman with progressive cognitive decline, pyramidal signs, and bilateral cataract was treated by chenodeoxycholic acid following the diagnosis of cerebrotendinous xanthomatosis due to a homozygous variant in CYP27A1. A 32-year-old man with adult-onset spastic paraplegia, in whom a variant in ABCD1 confirmed an X-linked adrenoleukodystrophy, was treated with corticoids for adrenal insufficiency. The third patient, a 28-year-old woman with early-onset developmental delay, epilepsy, and movement disorders was treated with a ketogenic diet following the identification of a variant in SLC2A1, confirming a glucose transporter type 1 deficiency syndrome. This case study illustrates the challenges in the timely diagnosis of medically actionable neurogenetic conditions, but also the considerable potential for improving patient health through modern sequencing technologies.
Databáze: OpenAIRE